33 A 74,
A 74, 33,
Atracurium,
Atracurium Besilate,
Atracurium Besylate,
Atracurium Dibesylate,
Besilate, Atracurium,
BW 33A,
BW-33A,
BW33A,
Relatrac,
Tracrium,
Atracurium besylate,
64228-81-5,
Atracurium besilate,
Tracrium,
Atracurii besilas,
Besilate d'atracurium,
Besilato de atracurio,
Atracurium (besylate),
BW 33A,
BW-33A,
Tracrium Preservative Free,
Atracurii besilas [INN-Latin],
BW 33 A,
Besilate d'atracurium [INN-French],
EINECS 264-743-4,
Atracurium Besylate Preservative Free,
Besilato de atracurio [INN-Spanish],
33 A 74,
CHEBI:2915,
Atracurium besilate (INN),
Atracurium besilate [INN],
Atracurium besylate, 96%,
2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester,
benzenesulfonate; 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate,
Pentamethylen bis(3-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-methyl-2-isochinolyl)propionat) bis(benzolsulfonat),
96946-42-8,
2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate,
Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate,
C53H72N2O12,
51W89,
hydro-1H-isoquinolin-2-ium-2-yl]propanoate,
UNII-40AX66P76P,
Atracurium besylate [USAN:BAN],
Atracurium besylate [USAN:USP],
atracurium-besylate,
NCGC00017127-01,
C65H82N2O18S2,
Tracrium (TN),
benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-di,
CAS-64228-81-5,
PubChem3018,
K027,
AC1L2HUI,
DSSTox_CID_2630,
Atracurium besylate (USP),
atracurium dibenzenesulfonate,
DSSTox_RID_76665,
DSSTox_GSID_22630,
SCHEMBL41251,
CHEMBL1200527,
DTXSID6022630,
HY-B0292A,
XXZSQOVSEBAPGS-UHFFFAOYSA-L,
40AX66P76P,
HMS1568A11,
HMS2095A11,
HMS3651C21,
HMS3712A11,
Pharmakon1600-01505872,
benzenesulfonate; 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1S,2S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propan,
KS-00000L5H,
Tox21_110790,
CA0147,
NSC760047,
AKOS015895831,
AB07163,
AN-6664,
Atracurium besylate, mixture of isomers,
CCG-213566,
CS-2306,
DB00732,
NC00429,
NSC-760047,
NCGC00262598-01,
NCGC00262598-02,
2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium] Dibenzenesulfonate,
AN-15362,
AS-14131,
AB1004899,
LS-176358,
TL8004537,
A2566,
FT-0659516,
SW197148-4,
Atracurium besylate, >=98% (HPLC), powder,
D00758,
A834680,
SR-01000781272,
I06-1457,
I14-0811,
Q-101018,
Q-200864,
SR-01000781272-3,
Atracurium besylate, European Pharmacopoeia (EP) Reference Standard,
Atracurium besylate, United States Pharmacopeia (USP) Reference Standard,
Atracurium for impurity F identification, European Pharmacopoeia (EP) Reference Standard,
Atracurium for peak identification, European Pharmacopoeia (EP) Reference Standard,
2,2'-(3,3'-(pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium) benzenesulfonate,
2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium, dibenzenesulfonate (9CI); Atracurium besilate; Atracurium besylate; Atracurium dibesilate,
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate,
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-{[3,4-bis(methyloxy)phenyl]methyl}-2-methyl-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate,
benzenesulfonate; 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoic acid 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]-1-oxopropoxy]pentyl ester,
Atracurium,
Nimbex,
letrozole,
Cisatracurium,
Relatrac,
Atracurium Dibesylate,
Cisatracurium besylate,
Cisatracuriumbesylate,
Cisapride monohydrate,
Besilate, Atracurium,
K027 cpd,
UNII-80YS8O1MBS,
BW33A,
Cisatracurium besylate [USAN],
NIMBEX PRESERVATIVE FREE,
CID47320,
Cisatracurium besylate [USAN:BAN],
MFCD00797403,
ACN-034405,
C53H72N2O12.2C6H5O3S,
CS-O-00905,
CS-O-06268,
Atracurium besylate (mixture of isomers),
C65-H82-N2-O18-S2,
Atracurium besylate 1R-cis,1R'-cis form,
C481758,
D001279,
A 74, 33,
64228-79-1,
1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide,
Atracurium besylate, 98%, a neuromuscular blocking agent - 100MG 100mg,
(1R,2R)-2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester,
112809-51-5,
2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[(3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-ISOQUINOLINIUM DIBENZENESULFONATE,
2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium,benzenesulfonate (1:2),
Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,
Isoquinolinium, 2,2'-[1,5-pentanodiilbis[oxi (3-oxo-3,1-propanodiil)]] bis [1-[(3,4-dimetoxifenil) metil]-1,2,3,4-tetrahidro-6,7-dimetoxi-2-metil-, benzenosulfonato (1:2),